KCM
AGN.PRA

Kingdon Capital Management’s Allergan plc AGN.PRA Stock Holding History

Kingdon Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,000
Closed -$2.29M – 160
2016
Q4 		$2.29M Buy
+3,000
New +$2.27M 0.11% 107
2016
Q3 		– Hold
0
– – – 52
2016
Q2 		– Hold
0
– – – 30
2016
Q1 		– Sell
-17,500
Closed -$16.7M – 46
2015
Q4 		$18M Buy
17,500
+7,500
+75% +$7.53M 0.88% 33
2015
Q3 		$9.44M Sell
10,000
-20,500
-67% -$21.4M 0.45% 56
2015
Q2 		$31.9M Buy
+30,500
New +$31.9M 1.25% 17

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Kingdon Capital Management's AGN.PRA Position: Q1 2017 in Review

Kingdon Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2017, closing a stake of 3,000 shares — an estimated $2.29M sold.

Kingdon Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 4 quarters. The position peaked at $31.9M in Q2 2015. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2017.

  • Kingdon Capital Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Kingdon Capital Management sold 3,000 Allergan plc shares in Q1 2017, an estimated $2.29M.
  • Kingdon Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 4 quarters.
  • Kingdon Capital Management's Allergan plc position peaked at $31.9M in Q2 2015.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Kingdon Capital Management's 13F filing for Q1 2017, filed 15 May 2017.